Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-22Clinical Trial Update: 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy [Phase 4]
Phase 4 trial update evaluating the 23-valent pneumococcal polysaccharide vaccine in patients with juvenile idiopathic arthritis receiving a…
-
FDA approval · 2014-05-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited under BLA125057.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Internet Self-Management Program With Telephone Support for Adolescents With Arthritis [NA]
Completed clinical trial assessing an internet self-management program with telephone support for adolescents with Juvenile Idiopathic Arthr…
-
CLINICAL_TRIALS research · 2013-12-31Clinical Trial Update: Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis [Phase 4]
Phase 4 clinical trial update investigating the efficacy of Leflunomide in Juvenile Idiopathic Arthritis. Sponsor: Mashhad University of Med…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: PEAK Study (Physical Exercise and Activity in Kids) [Phase 2]
Phase 2 clinical trial update for the PEAK study evaluating physical exercise and activity in children with Juvenile Idiopathic Arthritis (c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2013-12-10Clinical Trial Update: Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab
Update describing a request for a single-patient IND for compassionate/emergency use of tocilizumab in juvenile idiopathic arthritis; the tr…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA [NA]
Clinical trial update on foot orthoses for pain, quality of life, and gait in children with Juvenile Idiopathic Arthritis. The study (NCT020…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) [Phase 3]
Phase 3 trial of meloxicam (Mobic) in juvenile idiopathic arthritis has completed; the update confirms study status but does not provide res…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) [Phase 3]
A Phase 3 double-blind trial evaluating the efficacy and safety of meloxicam oral suspension in juvenile idiopathic arthritis has completed.
-
FDA approval · 2013-10-11FDA Approved: OTREXUP — Original Application (Antares Pharma, Inc.)
FDA approved OTREXUP, a subcutaneous methotrexate injection from Antares Pharma, under an original NDA for autoimmune conditions including r…
-
CLINICAL_TRIALS research · 2013-09-09Clinical Trial Update: NEMOS in Normal Volunteer and JIA Study [NA]
This clinical trial update concerns the NEMOS study in normal volunteers and patients with juvenile idiopathic arthritis, sponsored by Karin…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis [Phase 2]
A completed Phase 2 trial evaluating calcium supplements for supporting bone health in youths with juvenile idiopathic arthritis.
-
FDA approval · 2013-06-13FDA Approved: MELOXICAM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for meloxicam from Unichem Pharmaceuticals (USA), Inc., enabling a generic version of the NSAID for …
-
FDA approval · 2013-06-12FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Meloxicam (Carlsbad Technology, Inc.), a generic NSAID, under ANDA077918. The approval concerns …
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis [Phase 4]
A Phase 4 trial evaluating early aggressive drug therapy for Juvenile Idiopathic Arthritis has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Jointstrong Intervention for Juvenile Arthritis [NA]
The document reports the completion of a clinical trial evaluating Jointstrong Intervention for juvenile arthritis, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Clinical trial registry update for etanercept (Enbrel) in children with juvenile idiopathic arthritis shows the study status as completed.
-
FDA approval · 2013-04-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2013-02-07FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new dosage form for the Aleve product line, expanding th…
-
FDA approval · 2012-12-10FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation.
-
FDA approval · 2012-12-04FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis [Phase 3]
A Phase 3 study of tocilizumab in active polyarticular juvenile idiopathic arthritis has completed, with results posted in 2012.
-
FDA approval · 2012-09-28FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2012-09-28FDA Approved: INDOMETHACIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' indomethacin as an original ANDA (generic) application, making Indomethacin available as a generic …
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis [Phase 3]
A Phase 3 clinical trial evaluating etanercept in three subtypes of juvenile idiopathic arthritis has completed and results have been posted…